Fri. Dec 9th, 2022
Piramal Pharma completes 20% stake sale to Carlyle Group for Rs 3,523.40 crore This transaction is one of the largest private equity deals in the Indian pharmaceutical sector. It provides Piramal Pharma Ltd (PPL) growth capital that enables it to invest in accelerated business growth through both organic and inorganic opportunities, the statement said.